{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:55:40Z","timestamp":1762001740201},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,28]],"date-time":"2014-02-28T00:00:00Z","timestamp":1393545600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s11657-013-0169-5","type":"journal-article","created":{"date-parts":[[2014,2,27]],"date-time":"2014-02-27T05:57:12Z","timestamp":1393480632000},"source":"Crossref","is-referenced-by-count":24,"title":["Glucocorticoids predict 10-year fragility fracture risk in a population-based ambulatory cohort of men and women: Canadian Multicentre Osteoporosis Study (CaMos)"],"prefix":"10.1007","volume":"9","author":[{"name":"CaMos Research Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Ioannidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Pallan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Mulgund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lehana","family":"Thabane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth S.","family":"Davison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Josse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher S.","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy","family":"Kreiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojciech P.","family":"Olszynski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerilynn C.","family":"Prior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanveer","family":"Towheed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,28]]},"reference":[{"key":"169_CR1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"TP Staa Van","year":"2000","unstructured":"Van Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fracture. J Bone Miner Res 15:993\u20131000","journal-title":"J Bone Miner Res"},{"key":"169_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF01623380","volume":"2","author":"P Chavassieux","year":"1993","unstructured":"Chavassieux P, Pastoureau P, Chapuy MC, Delmas PD, Meunier PJ (1993) Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study. Osteoporos int 2:97\u2013102","journal-title":"Osteoporos int"},{"key":"169_CR3","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0026-0495(89)90208-4","volume":"38","author":"A Barbarino","year":"1989","unstructured":"Barbarino A, DeMarinis L, Folli G, Tofani A, Della Casa S, D\u2019Amico C et al (1989) Corticotrophin-releasing hormone inhibition of gonadotropin secretion during the menstrual cycle. Metabolism 38:504\u2013506","journal-title":"Metabolism"},{"key":"169_CR4","first-page":"777","volume":"13","author":"TP Staa Van","year":"2000","unstructured":"Van Staa TP, Leufkens HGM, Cooper C (2000) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777\u2013787","journal-title":"Osteoporos Int"},{"issue":"12","key":"169_CR5","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","volume":"39","author":"TP Staa Van","year":"2000","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Oral corticosteroids and fracture risk: relationship to daily and cumulative doses. Rheumatology (Oxford) 39(12):1383\u20131389","journal-title":"Rheumatology (Oxford)"},{"key":"169_CR6","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1503\/cmaj.100771","volume":"182","author":"A Papaioannou","year":"2010","unstructured":"Papaioannou A, Morin S, Cheung A, Atkinson S, Brown JP, Feldman S et al (2010) Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 182:1864\u20131872","journal-title":"CMAJ"},{"key":"169_CR7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-008-0560-z","volume":"19","author":"Kanis","year":"2008","unstructured":"Kanis, Burlet N, On behalf of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) (2008) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 19:399\u2013428","journal-title":"Osteoporos Int"},{"key":"169_CR8","unstructured":"National Osteoporosis Foundation (2008) Clinician\u2019s guide to prevention and treatment of osteoporosis. Washington, DC: National Osteoporosis Foundation. www.nof.org . Accessed September 2013"},{"key":"169_CR9","unstructured":"Kanis JA on behalf of the World Health Organization Scientific Group (2008) assessment of osteoporosis at the primary health-care level. Technical report. Who collaborating Centre, University of Sheffield, UK. Accessed at www.shef.ac.uk\/FRAX\/ . Accessed September 2013"},{"key":"169_CR10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385\u2013397","journal-title":"Osteoporos Int"},{"key":"169_CR11","first-page":"178","volume":"56","author":"K Siminoski","year":"2005","unstructured":"Siminoski K, Leslie W, Frame H, Hodsman A, Josse RG, Khan A et al (2005) Recommendations for bone mineral density reporting in Canada. Can Assoc Radiol J 56:178\u2013188","journal-title":"Can Assoc Radiol J"},{"key":"169_CR12","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00198-010-1445-5","volume":"6","author":"WD Leslie","year":"2011","unstructured":"Leslie WD, Berger C, Langsetmo L, Lix LM, Adachi JD, Hanley G et al (2011) Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: from the CaMos and Manitoba cohorts. Osteoporos Int 6:1873\u20131883","journal-title":"Osteoporos Int"},{"key":"169_CR13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1017\/S0714980800009934","volume":"18","author":"N Kreiger","year":"1999","unstructured":"Kreiger N, Tenenhouse A, Joseph L, Mackenzie T, Poliquin S, Brown JP et al (1999) The Canadian Multicentre Osteoporosis Study (CaMos): background, rationale, methods. Can J Aging 18:376\u2013387","journal-title":"Can J Aging."},{"key":"169_CR14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s001980070066","volume":"8","author":"SA Jackson","year":"2000","unstructured":"Jackson SA, Tenenhouse A, Robertson L, CaMos Study Group (2000) Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int 8:680\u2013687","journal-title":"Osteoporos Int"},{"key":"169_CR15","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1007\/s00198-012-1931-z","volume":"23","author":"JE Tarride","year":"2012","unstructured":"Tarride JE, Hopkins RB, Leslie WE, Morin S, Adachi JD, Papaioannou A et al (2012) The burden of illness of osteoporosis in Canada. Osteoporos Int 23:2591\u201325600","journal-title":"Osteoporos Int"},{"key":"169_CR16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s001980170017","volume":"12","author":"JD Adachi","year":"2001","unstructured":"Adachi JD, Ioannidis G, Berge C, Joseph L, Papaioannou A, Pickard L et al (2001) The influence of osteoporotic fractures on Health related quality of life in community dwelling men and women across Canada. Osteoporos Int 12:903\u2013908","journal-title":"Osteoporos Int"},{"key":"169_CR17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1503\/cmaj.081720","volume":"181","author":"G Ioannidis","year":"2009","unstructured":"Ioannidis G, Papaioannou A, Hopman WM, Akhtar-Danesh N, Anastassiades T, Pichard L et al (2009) Relation between fractures and mortality: results from the Canadian multicentre osteoporosis study. CMAJ 181:265\u2013271","journal-title":"CMAJ"},{"key":"169_CR18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","volume":"19","author":"JA Kanis","year":"2004","unstructured":"Kanis JA, Johansson H, Oden A, Johnell O, de Laet C, Melton LJ III et al (2004) A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res 19:893\u2013899","journal-title":"J Bone Miner Res"},{"key":"169_CR19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00198-010-1524-7","volume":"22","author":"JA Kanis","year":"2011","unstructured":"Kanis JA, Johansson H, Oden A, McCloskey M (2011) Guidance for the adjustment of FRAX according to the dose of glucocorticoids. Osteoporos Int 22:809\u2013816","journal-title":"Osteoporos Int"},{"key":"169_CR20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00198-003-1548-3","volume":"15","author":"M Steinbuch","year":"2004","unstructured":"Steinbuch M, Youket TE, Cohen S (2004) Oral glucocorticoid use is associated with an increased risk of fracture. Osteoporos Int 15:323\u2013328","journal-title":"Osteoporos Int"},{"key":"169_CR21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200084","volume":"13","author":"TP Staa Van","year":"2002","unstructured":"Van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777\u2013787","journal-title":"Osteoporos Int"},{"key":"169_CR22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF00298431","volume":"57","author":"JK Salto","year":"1995","unstructured":"Salto JK, Davis JW, Wasnich RD, Ross PD (1995) Users of low-dose glucocorticoids have increases bone loss rates: a longitudinal study. Calcif Tissue Int 57:115\u2013119","journal-title":"Calcif Tissue Int"},{"key":"169_CR23","first-page":"1745","volume-title":"Osteoporosis 1990 (3)","author":"JD Adachi","year":"1990","unstructured":"Adachi JD, Bensen WG, Bell MJ et al (1990) Corticosteroid induced osteoporosis: follow-up over 3 years. In: Christiansen C, Overgaard K (eds) Osteoporosis 1990 (3). Third International Symposium on Osteoporosis, Copenhagen, pp 1745\u20131747"},{"key":"169_CR24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00198-005-1923-3","volume":"17","author":"K Natsui","year":"2006","unstructured":"Natsui K, Tanaka K, Suda M, Yasoda A, Sakuma Y, Ozasa A et al (2006) High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass. Osteoporos Int 17:105\u2013108","journal-title":"Osteoporos Int"},{"key":"169_CR25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00223-010-9392-x","volume":"87","author":"S Gonnelli","year":"2010","unstructured":"Gonnelli S, Caffarelli C, Maggi S, Guglielmi G, Siviero P, Rossi S et al (2010) EOLO study group. Effect of inhaled glucocorticoids and beta(2) agonists on vertebral fracture risk in COPD patients: the EOLO study. Calcif Tissue Int 87:137\u2013147","journal-title":"Calcif Tissue Int"},{"key":"169_CR26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00223-008-9124-7","volume":"82","author":"P Vestergaard","year":"2008","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2008) Fracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fractures. Calcif Tissue Int 82:249\u2013257","journal-title":"Calcif Tissue Int"},{"key":"169_CR27","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00198-010-1329-8","volume":"22","author":"SM Cadarette","year":"2011","unstructured":"Cadarette SM, Jaglal SB, Raman-Wilms L, Beaton DE, Paterson JM (2011) Osteoporosis quality indicators using healthcare utilization data. Osteoporos Int 22:1335\u20131342","journal-title":"Osteoporos Int"},{"issue":"3","key":"169_CR28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.GME.0000094210.15096.FD","volume":"11","author":"Z Chen","year":"2004","unstructured":"Chen Z, Kooperberg C, Pettinger MB, Bassford T, Cauley JA, LaCroix AZ et al (2004) Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women\u2019s Health Initiative observational study and clinical trials. Menopause 11(3):264\u2013274","journal-title":"Menopause"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-013-0169-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11657-013-0169-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-013-0169-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T15:01:00Z","timestamp":1559401260000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11657-013-0169-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,28]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["169"],"URL":"https:\/\/doi.org\/10.1007\/s11657-013-0169-5","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"type":"print","value":"1862-3522"},{"type":"electronic","value":"1862-3514"}],"subject":[],"published":{"date-parts":[[2014,2,28]]},"article-number":"169"}}